Weekly chemotherapy with cisplatin and paclitaxel in advanced NSCLC: a phase II study

Monaldi Archives for Chest Disease

D. Ferrigno¹  M.C. Giordano¹  G. Buccheri¹ 

[1] Struttura Complessa di Pneumologia, Azienda Ospedaliera “S. Croce e Carle”, Cuneo;

关键词: Non-small cell lung cancer;    chemotherapy;    cisplatin;    paclitaxel;    first-line treatment;   

DOI  :  10.4081/monaldi.2006.568

来源: DOAJ

【 摘 要 】

Background. This phase II study was designed to assess the activity and toxicity of administration of the cisplatin/ paclitaxel combination in advanced non-small cell lung cancer (NSCLC). Methods. Eligibility criteria included: age up to 70 years, pathological diagnosis of NSCLC, inoperable disease or post-operative tumour recurrence, performance status

【 授权许可】

Unknown